The Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) multi-centre randomized clinical trial, which included 894 adults from HIC with HFrEF, concluded that NT-proBNP guided treatment does not offer superior benefit compared to the standard care of HFrEF [29]. The gene discussed is NPPB; the disease is heart failure.